NCT00688779View on ClinicalTrials.gov

Tolerability/Safety of Intranasal AZD8848 in Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season

PHASE1CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

April 30, 2009

Conditions
HealthyAllergic Rhinitis
Interventions
DRUG

AZD8848

Concentrate for nasal spray,solution 60 mg/g

DRUG

Placebo

Trial Locations (1)

Unknown

Research Site, Lund

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY